Private Trust CO Na Exelixis, Inc. Transaction History
Private Trust CO Na
- $938 Million
- Q1 2025
A detailed history of Private Trust CO Na transactions in Exelixis, Inc. stock. As of the latest transaction made, Private Trust CO Na holds 183 shares of EXEL stock, worth $7,885. This represents 0.0% of its overall portfolio holdings.
Number of Shares
183
Previous 150
22.0%
Holding current value
$7,885
Previous $4,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EXEL
# of Institutions
611Shares Held
257MCall Options Held
1.57MPut Options Held
730K-
Black Rock Inc. New York, NY33.5MShares$1.44 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA28.7MShares$1.24 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA22.5MShares$971 Million4.78% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny14.8MShares$639 Million0.88% of portfolio
-
State Street Corp Boston, MA11.8MShares$508 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $13.9B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...